More Articles

hospital
June 22, 2018 | Heart Failure

Heart failure patients treated at hospitals with lower 30-day mortality rates also enjoy a survival benefit one, three and even five years later, suggesting a short-term risk-standardized mortality rate (RSMR) may deserve additional weight…

Baylor St. Luke's Medical Center in Houston
June 18, 2018 | Heart Failure

Baylor St. Luke’s Medical Center in Houston reopened its heart transplant program June 15 after a

June 11, 2018 | Heart Failure

Researchers working on a trial for new stem cell therapy are aiming to revitalize damaged heart tissue of heart failure patients—while saving time and money. 

Scientists are researching how to take stem cells from the patient’s blood to…

June 11, 2018 | Heart Rhythm

Patients who progressed to having longer episodes of subclinical atrial fibrillation (SCAF) were more than four times as likely to be hospitalized for heart failure in a one-year span, according to a…

June 08, 2018 | Heart Failure

Measurements of malnutrition offer incremental prognostic value for patients with heart failure, but more work is needed to tease out which components of the condition are most crucial to calculate and treat, researchers reported in

June 06, 2018 | Heart Failure

The average hospital stay for pediatric patients requiring a ventricular assist device (VAD) spans nearly three months and costs $750,000, according to a registry analysis…

June 05, 2018 | Heart Failure

The authors of a study published in the Journal of the American College of…

June 04, 2018 | Heart Failure

The FDA has labeled Medtronic’s recall of its HeartWare Ventricular Assist Device (VAD) system as Class I, indicating a reasonable risk of serious injury or death. The electrical connection between the system’s power source—the battery, AC…

Baylor St. Luke's Medical Center in Houston
June 04, 2018 | Heart Failure

Baylor St. Luke’s Medical Center in Houston has temporarily suspended its heart transplant program, two weeks after a joint investigation by the Houston Chronicle and ProPublica…

June 01, 2018 | Heart Failure

Type 2 diabetics who take sodium-glucose co-transporter-2 (SGLT-2) inhibitors experience similar relative reductions in heart failure and mortality regardless of whether they have cardiovascular disease (CVD), according to a…

Blood test
June 01, 2018 | Heart Failure

Adding biomarkers to the validated Pooled Cohort Equation (PCE) can improve predictions of cardiovascular events including heart attack, stroke and heart failure among older patients, researchers reported in the

Cardiovascular

Severe and active atopic eczema in adulthood is associated with an increased risk for developing cardiovascular disease (CVD), including stroke, heart failure, myocardial infarction (MI) and atrial fibrillation (AFib), according to a new

May 30, 2018 | Heart Failure

Several models have been developed to predict mortality among heart failure patients, but clinicians remain reluctant to use them in everyday practice. In fact, fewer than 1 percent of patients received a prognostic estimate from their physicians…

May 29, 2018 | Heart Failure

Triggering a shift in fluids from the chest to the abdomen by blocking the splanchnic nerves has the potential to relieve acute heart failure symptoms, according to research presented May 26 at Heart Failure 2018 and published…

Protein
May 29, 2018 | Heart Failure

Middle-aged men who eat higher amounts of protein have a slightly elevated risk for heart failure (HF) than those who eat less protein, according to a new study published…

Nintendo Wii
May 29, 2018 | Heart Failure

Heart failure patients who were given instructions on how to use a Nintendo Wii device improved their exercise capacity and quality of life more than counterparts who were simply advised to exercise 30 minutes per day.

May 23, 2018 | Heart Failure

Patients with heart failure who describe themselves as being “socially isolated” have an increased…

The Abbott HeartMate 3 left ventricular assist system. When Medicare updated its policy on left ventricular assist devices (LVADs) in 2020, making it easier for heart failure patients to receive an LVAD at a health center that does not perform heart transplants, the change was designed to improve patient access and boost outcomes. However, new research published in JAMA Network Open suggests shift may have potentially caused patients to miss out on heart transplants they would have otherwise received.
May 23, 2018 | Heart Failure

The FDA has issued a Class I recall of the HeartMate 3 Left Ventricular Assist System (Abbott) because a malfunction in the device’s outflow graft assembly could lead to graft occlusion, possibly reducing or stopping blood flow.

Machine Learning
May 18, 2018 | Heart Failure

Researchers from the University of California, Los Angeles (UCLA) have developed a new algorithm that better predicts pre- and post-heart transplant survival than existing methods.

Dubbed “Trees of Predictors” (ToPs),…

May 17, 2018 | Heart Failure

A study published May 8 in the Journal of the American Heart Association suggests black and white patients with heart failure with reduced ejection fraction (HFrEF…

Jeffrey Morgan, MD
May 17, 2018 | Heart Failure

Baylor St. Luke’s Medical Center in Houston continues to tout itself as one of the top heart transplant centers in the country, even as quality measures lag well behind national averages.

An investigative story by the…